封面
市场调查报告书
商品编码
1517644

矿物质补充剂市场 - 按产品类型(钙、镁、铁、钾、锌)、配方(胶囊和片剂、液体)、应用(一般健康、骨骼和关节健康)、消费者群体、配销通路- 全球预测(2024 年 -第2032章

Mineral Supplements Market - By Product Type (Calcium, Magnesium, Iron, Potassium, Zinc), Formulation (Capsule & Tablets, Liquid), Application (General Health, Bone & Joint Health), Consumer Group, Distribution Channel - Global Forecast (2024 - 2032)

出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3个工作天内

价格
简介目录

矿物质补充剂市场规模预计 2024 年至 2032 年间复合年增长率为 4.7%。由于现代饮食和生活方式因素导致营养缺乏的风险,人们正在寻找补充剂来填补饮食中的空白。已开发国家的人口老化也推动了对骨骼健康和免疫系统抵抗力的矿物质补充剂的需求增加。根据世界卫生组织的数据,到 2030 年,全世界每 6 个人就有 6 人年龄超过 60 岁。

此外,运动员和运动者正在日常运动中添加矿物质补充剂,以优化表现、改善恢復并支持肌肉功能。由于运动员、健身影响者和健康专业人士的回馈,针对特定矿物质缺乏或表现目标的特殊配方的需求也有所增加。功能性饮料、蛋白质棒和其他方便的输送形式的不断转变也使用户更容易将矿物质补充剂纳入他们的日常生活中。

本产业分为产品类型、配方、应用、消费群体、配销通路和地区。

根据产品类型,铁补充剂领域的矿物质补充剂市场预计将在2024 年至2032 年间出现显着增长。铁缺乏症并支持整体健康。配方技术的快速改进将促进该领域的成长,以获得更好的铁片。

到2032 年,骨骼和关节健康应用领域的矿物质补充剂市场价值将录得显着增长。水平。钙、镁和维生素 D 等矿物质补充剂因促进骨骼健康和关节功能而广受欢迎。为了解决矿物质缺乏问题,骨质疏鬆症、关节炎和其他肌肉骨骼疾病的盛行率不断上升,正在推动该领域的成长。

到 2032 年,亚太地区矿物质补充剂市场规模将呈现可观增长。消费者正在认识到矿物质补充剂对健康的需求。医疗保健成本上升、零售扩张、政府对促进公共卫生和营养教育的支持以及矿物质补充剂采用率的增加将刺激该地区市场的成长。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 营养缺乏症盛行率上升
      • 老年人口增加
      • 人们对健康和保健的认识不断增强
      • 透过线上平台扩大可访问性
    • 产业陷阱与挑战
      • 严格的法规和不同的标准
      • 缺乏品质和误导性声明
  • 成长潜力分析
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:按产品类型,2021 - 2032 年

  • 主要趋势
  • 钙补充剂
  • 镁补充剂
  • 铁补充剂
  • 钾补充剂
  • 锌补充剂
  • 铬补充剂
  • 补硒
  • 其他补充剂

第 6 章:市场估计与预测:按配方划分,2021 - 2032 年

  • 主要趋势
  • 胶囊和片剂
  • 液体
  • 粉末
  • 软糖
  • 其他配方

第 7 章:市场估计与预测:按应用分类,2021 - 2032

  • 主要趋势
  • 整体健康
  • 骨骼和关节健康
  • 肠胃健康
  • 免疫支持
  • 其他应用

第 8 章:市场估计与预测:按消费者群体划分,2021 - 2032 年

  • 主要趋势
  • 成年人
  • 孕妇
  • 孩子们

第 9 章:市场估计与预测:按配销通路划分,2021 - 2032 年

  • 主要趋势
  • 药局和零售店
  • 超级市场和大卖场
  • 网上销售
  • 其他分销管道

第 10 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 11 章:公司简介

  • Abbott Laboratories
  • Amway Corp.
  • Bayer AG
  • Bio Botanica, Inc.
  • BIOVEA
  • Catalent, Inc.
  • Dr. Paul Lohmann GmbH & Co. KGaA
  • Glanbia plc
  • Herbalife International of America, Inc.
  • Mineral Resources International, Inc.
  • Nestlé S.A.
  • NV Labs
  • Pfizer Inc.
  • Pharmavite
  • Sanofi
简介目录
Product Code: 9308

Mineral supplements market size is expected to witness 4.7% CAGR between 2024 and 2032. Consumer awareness of health importance is leading to the increased interest in dietary supplements. With risks of nutritional deficiencies due to modern diets and lifestyle factors, people are looking for supplements to fill the gaps in their diets. The aging population in developed countries is also driving the increased need for mineral supplements for bone health and immune system resistance. As per WHO, by 2030, every 6th person in the world will be over 60 years old.

Moreover, athletes and exercisers are adding mineral supplements to their routines to optimize performance, improve recovery and support muscle function. The demand for special formulations that target specific mineral deficiencies or performance goals has also increased due to the feedback from athletes, fitness influencers and health professionals. The rising shift towards functional beverages, protein bars, and other convenient delivery formats has also made it easier for users to incorporate mineral supplements into their daily routine.

The industry is classified into product type, formulation, application, consumer group, distribution channel and region.

Based on product type, the mineral supplements market from the iron supplements segment is slated to depict significant growth between 2024 to 2032. Of late, the demand for iron supplements to address deficiencies and support the overall health due to increased awareness of the consequences of iron deficiency is growing. The rapid improvements in formulation technology for better iron tablets will add to the segment growth.

Mineral supplements market value from the bone & joint health application segment will record significant growth rate through 2032. With the growing population, there is rising awareness regarding bone density and joint flexibility to support the overall mobility and standard of life. Mineral supplements like calcium, magnesium, and vitamin D are popular for promoting bone health and joint function. Rising prevalence of osteoporosis, arthritis, and other musculoskeletal conditions to address mineral deficiency is driving the segment growth.

Asia Pacific mineral supplements market size will exhibit decent growth through 2032. Rapid urbanization and changing eating habits have led to the increase in nutritional deficiencies, especially in developing economies. Consumers are recognizing the need for mineral supplements for health. Rising healthcare costs , retail expansion and government support for promoting public health and nutrition education as well as increasing mineral supplement adoption will stimulate the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of nutritional deficiencies
      • 3.2.1.2 Increasing elderly population
      • 3.2.1.3 Growing awareness for health and wellness
      • 3.2.1.4 Expanded accessibility by online platform
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulations and varying standards
      • 3.2.2.2 Lack of quality and misleading claims
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Calcium supplements
  • 5.3 Magnesium supplements
  • 5.4 Iron supplements
  • 5.5 Potassium supplements
  • 5.6 Zinc supplements
  • 5.7 Chromium supplements
  • 5.8 Selenium supplements
  • 5.9 Other supplements

Chapter 6 Market Estimates and Forecast, By Formulation, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Capsules & tablets
  • 6.3 Liquid
  • 6.4 Powder
  • 6.5 Gummies
  • 6.6 Other formulations

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 General health
  • 7.3 Bone & joint health
  • 7.4 Gastrointestinal health
  • 7.5 Immune support
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By Consumer Group, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Adults
  • 8.3 Pregnant women
  • 8.4 Children

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Pharmacies & retail stores
  • 9.3 Supermarkets & hypermarkets
  • 9.4 Online sales
  • 9.5 Other distribution channels

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 South Africa
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 Abbott Laboratories
  • 11.2 Amway Corp.
  • 11.3 Bayer AG
  • 11.4 Bio Botanica, Inc.
  • 11.5 BIOVEA
  • 11.6 Catalent, Inc.
  • 11.7 Dr. Paul Lohmann GmbH & Co. KGaA
  • 11.8 Glanbia plc
  • 11.9 Herbalife International of America, Inc.
  • 11.10 Mineral Resources International, Inc.
  • 11.11 Nestlé S.A.
  • 11.12 NV Labs
  • 11.13 Pfizer Inc.
  • 11.14 Pharmavite
  • 11.15 Sanofi